Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 35.0% in December

Venus Concept Inc. (NASDAQ:VERO) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 93,597 shares, a drop of 35.0% from the November 30th total of 144,013 shares. Based on an average daily trading volume, of 645,091 shares, the days-to-cover ratio is presently 0.1 days. Approximately 9.1% of the shares of the company are sold short. Approximately 9.1% of the shares of the company are sold short. Based on an average daily trading volume, of 645,091 shares, the days-to-cover ratio is presently 0.1 days.

Venus Concept Trading Down 1.1%

Shares of VERO stock opened at $1.74 on Friday. Venus Concept has a 1 year low of $1.63 and a 1 year high of $14.50. The firm’s fifty day simple moving average is $1.95 and its 200 day simple moving average is $2.26. The firm has a market capitalization of $2.47 million, a P/E ratio of -0.04 and a beta of -0.11. The company has a current ratio of 0.90, a quick ratio of 0.59 and a debt-to-equity ratio of 1.59.

Venus Concept (NASDAQ:VERO) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($12.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.61) by ($8.53). The company had revenue of $13.78 million during the quarter, compared to the consensus estimate of $14.48 million. Venus Concept had a negative net margin of 92.76% and a negative return on equity of 1,904.25%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Venus Concept in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

About Venus Concept

Venus Concept Ltd. (NASDAQ: VERO) is a Canada-based medical aesthetic device company that designs, develops and commercializes minimally and noninvasive solutions for face and body rejuvenation. The company’s core product portfolio leverages proprietary technologies such as multi-polar radio frequency, pulsed electromagnetic fields and intense pulsed light to offer treatments for skin tightening, body contouring, wrinkle reduction and vascular lesion removal.

Among its flagship offerings are the Venus Legacy platform, which combines radio frequency and electromagnetic pulses for cellulite reduction and circumferential reduction, and the Venus Versa system, a multi-application device for facial revitalization, acne treatment, hair removal and photorejuvenation.